| Muscular Atrophy |
0 |
0.9 |
| Amyotrophic Lateral Sclerosis |
0 |
1 |
| Clinical Research |
0 |
0.4 |
| Brain |
0 |
0.99 |
| Blood-Brain Barrier |
0 |
0.27 |
| Mechanical Ventilation |
0 |
0.16 |
| Europe |
0 |
0.13 |
| Otolaryngology |
0 |
0.13 |
| Quality of Life |
0 |
0.13 |
| Huntington Disease |
0 |
0.08 |
| Multiple Sclerosis |
0 |
0.08 |
| Parkinson Disease |
0 |
0.08 |
| Toxicology |
0 |
0.08 |
| Blood |
0 |
0.07 |
| Food and Drug Administration (FDA) |
0 |
0.07 |
| Ischemia |
0 |
0.07 |
| Neurodegenerative Diseases |
0 |
0.07 |
| Noninvasive Ventilation |
0 |
0.07 |
| Tracheostomy |
0 |
0.07 |
| Virginia |
0 |
0.07 |